Clinical Research Directory

Inclusion Criteria: * Have fully understood the test and voluntarily signed the informed consent; * When signing the informed consent form, the age of male or female subjects must be ≥ 18 years old; * The onset time of atopic dermatitis was at least 1 year at the time of screening, and the subjects met the Hanifin and Rajka criteria for atopic dermatitis at the time of screening; * For women with reproductive ability and all male subjects, during the trial period and within 6 months after the discontinuation of the trial drug, they must maintain abstinence or contraception, including but not limited to physical and drug contraception. * The subjects were able to communicate well and agreed to follow the study and follow-up procedures. Exclusion Criteria: * The investigator considers that any subjects are not suitable to participate in the trial.